Andrew I. Koven
2017
In 2017, Andrew I. Koven earned a total compensation of $1.2M as President and Chief Business Officer at Aralez Pharmaceuticals, a 80% decrease compared to previous year.
Compensation breakdown
| Option Awards | $114,002 |
|---|---|
| Salary | $463,500 |
| Stock Awards | $569,053 |
| Other | $12,000 |
| Total | $1,158,555 |
Koven received $569.1K in stock awards, accounting for 49% of the total pay in 2017.
Koven also received $114K in option awards, $463.5K in salary and $12K in other compensation.
Rankings
In 2017, Andrew I. Koven's compensation ranked 8,261st out of 14,666 executives tracked by ExecPay. In other words, Koven earned more than 43.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,261 out of 14,666 | 44th |
Division Manufacturing | 3,121 out of 5,772 | 46th |
Major group Chemicals And Allied Products | 1,030 out of 2,075 | 50th |
Industry group Drugs | 810 out of 1,731 | 53rd |
Industry Pharmaceutical Preparations | 633 out of 1,333 | 53rd |
Source: SEC filing on May 18, 2018.
Koven's colleagues
We found five more compensation records of executives who worked with Andrew I. Koven at Aralez Pharmaceuticals in 2017.
2017
Adrian Adams
Aralez Pharmaceuticals
Chief Executive Officer
2017
Scott Charles
Aralez Pharmaceuticals
Chief Financial Officer
2017
James Tursi
Aralez Pharmaceuticals
Chief Medical Officer
2017
Mark Glickman
Aralez Pharmaceuticals
Former Chief Commercial Officer
2017
Michael Kaseta
Aralez Pharmaceuticals